None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Individuals aged 20 years and above but below 65 years, regardless of gender. (2) Those diagnosed with gingivitis and mild periodontitis. (3) Individuals who voluntarily provided written consent to this human application trial through the Informed Consent Form.
Exclusion criteria
Exclusion criteria: (1) Patients with severe or advanced periodontitis. (2) Individuals who have undergone scaling and preventive periodontal treatment within the last 3 months from the date of consent form completion. (3) Smokers. (4) Individuals with orthodontic appliances. (5) Those with pathological findings in the oral tissues or requiring treatment from other departments. (6) Individuals requiring immediate treatment for dental caries. (7) Individuals with uncontrolled chronic conditions such as diabetes, liver disease, heart disease, kidney disease, bleeding disorders, or other chronic illnesses. (8) Those with clinically significant immune, infectious, neoplastic, or psychiatric disorders requiring treatment. (9) Users of medications that may affect periodontal health (nifedipine, phenytoin, cyclosporine). (10) Those who have taken antibiotics within the last 4 weeks, are currently taking antibiotics, or are planning to receive antibiotics in the future. (11) Individuals who have received investigational drugs or non-investigational medicinal products for clinical trials within 30 days prior to participating in the clinical trial. (12) Pregnant or lactating women, or fertile women not using acceptable contraceptive methods. (13) Individuals deemed unsuitable as subjects for this trial by the clinical trial investigator and personnel for reasons other than those mentioned above.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical outcomes(VAS, PD, BOP, GI, PI, EQ-5D-5L) | — |
Secondary
| Measure | Time frame |
|---|---|
| Feasibility Outcomes ("Recruitment Rate, Adherence Rate, Completion Rate);Economic Evaluation Indicators (Incremental Cost-Utility Ratio and Incremental Cost-Effectiveness Ratio between the Test Group and Control Group) | — |
Countries
Korea, Republic of
Contacts
Dongguk University Gyeongju Campus